PhD CChem FRSC
Antony is a CMC, drug development and regulatory consultant. He has a diverse background in drug research and development with experience in assisting small or virtual (bio)pharma companies towards, into and through clinical studies. Development support is provided during preclinical and clinical development, including registration ready activities for MAA, NDA and BLA.
Advice is provided to clients developing peptides, semi-synthetic natural products, conventional small molecules, ATMPs, antibody-drug conjugates, biosimilars, biobetters, vaccines, therapeutic proteins, monoclonal antibodies and novel biologics.